The Oncologist, Vol. 11, No. 7, 849-850, July 2006; doi:10.1634/theoncologist.11-7-849 © 2006 AlphaMed Press
The Molecular Perspective: Tissue FactorThe Scripps Research Institute, Department of Molecular Biology, La Jolla, California, USA Correspondence: David S. Goodsell, Ph.D., Associate Professor, The Scripps Research Institute, Department of Molecular Biology, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. Telephone: 858-784-2839; Fax: 858-784-2860; e-mail: goodsell{at}scripps.edu Web site: http://www.scripps.edu/goodsell Received June 19, 2006; accepted for publication June 19, 2006.
Access and take the CME test online and receive 1 AMA PRA Category 1 CreditTM at CME.TheOncologist.com
Blood clotting is a delicate business that must be carefully controlled. The blood must be ready to clot at a moments notice since damage can occur at any time. But it must clot just enough to stanch the flow of blood at the wound but not anywhere else in the body. Many deadly diseases with sudden onsets are disorders of blood clotting, including hemophilia, heart attack, and stroke. It is becoming clear that metastasis also has close ties with blood-clotting machinery. The circulatory system uses a very simple method to locate wounds quickly and precisely. Cells in the neighborhood around blood vessels have tissue factor on their surfaces, whereas cells inside the vessels do not. Most of the time, the blood flows normally through the vessels and never comes into contact with tissue factor. But when the vessel is broken, blood flows out and finds tissue factor on epithelial or muscle cell surfaces. This is the signal that something is wrong.
A cascade of protein activation is used to build the clot. One pathway starts with tissue factor, which activates factor VII, which then activates factor X, which activates thrombin, which finally activates the fibrin that forms the clot (Fig. 1 In recent years, research has shown that tissue factor plays more than just this passive role as trigger. It is tied to cell signaling processes that activate the machinery needed for cell growth and mobility. The details are complex and dependent on the cell type, but the complex of tissue factor with factor VII is a key element in initiating the signaling events, either by directly signaling through tissue factor or by together activating a neighboring cell receptor. This role in cell signaling makes tissue factor a player in metastasis of cancer cells. When cancer cells metastasize, they must overcome many cellular hurdles as they break away from the tumor, travel through the blood, and take up residence in a distant part of the body. The signals sent by tissue factor can assist tumor cells by promoting many processes that are normally inhibited in healthy cells. These include enhanced growth of blood vessels in the neighborhood and inhibition of apoptosis.
The author indicates no potential conflicts of interest.
Robert HR, Monroe DM, Hoffman M. Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis. In: Williams Hematology, Seventh Edition. McGraw-Hill, 2006.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||